Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Tumor Embolization Devices Market Growth Potential: How Will Market Size Shift Through 2030?
The market size for tumor embolization devices has seen strong expansion in recent years. It is projected to increase from $1587.48 billion in 2025 to $1732.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. This historic growth can be attributed to the broader application of interventional oncology practices, a rise in the incidence of solid tumors, the growing acceptance of minimally invasive procedures, the development of advanced catheter technologies, and the expanding utilization of embolization in cancer treatment.
The tumor embolization devices market is projected to experience robust expansion over the coming years. This market is set to reach $2464.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This anticipated growth is driven by factors such as increased investments in interventional oncology, a heightened demand for combination cancer therapies, the widening scope of targeted drug delivery techniques, an increasing emphasis on organ-sparing treatments, and the greater integration of imaging-guided interventions. Key developments expected during this period involve the rising adoption of targeted embolization therapies, a surge in demand for drug-eluting embolic agents, the expanding application of image-guided embolization procedures, a broadening of minimally invasive oncology interventions, and a stronger focus on precise tumor targeting.
Get A Free Sample Report With In-Depth Market Insights:
Tumor Embolization Devices Market Growth Drivers: What’s Behind The Acceleration?
The global increase in cancer diagnoses is expected to fuel the expansion of the Tumor Embolization Devices Market throughout the forecast period. Cancer is characterized by the uncontrolled proliferation of abnormal cells, which can spread within the body. This surge in cancer cases is primarily influenced by aging demographics, as older individuals face a greater likelihood of developing cancer due to accumulated genetic mutations and prolonged exposure to various risk factors. Tumor embolization devices play a crucial role in managing this rising incidence by offering a precise, minimally invasive treatment that restricts blood supply to tumors, thereby hindering their growth and enhancing patient recovery. For example, in 2023, the American Cancer Society Inc., a US-based non-profit health organization, reported 1,958,310 new cancer diagnoses in the US, which represents an increase from the over 1,918,030 new cases recorded in 2022. Consequently, the escalating global cancer incidence rate is projected to significantly elevate the demand within the tumor embolization market in the coming years.
Tumor Embolization Devices Market Segment Trends And Revenue Contributors
The tumor embolization devices market covered in this report is segmented –
1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers
Subsegments:
1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres
2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol – PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)
Tumor Embolization Devices Market Trends: What’s Defining The Industry’s Next Phase?
Major companies within the tumor embolization devices market are intensifying their efforts to introduce innovative medications, such as Eye90, in order to maximize their market revenue. Eye90 microspheres function as a Y90 radioembolization device specifically engineered for treating liver tumors, particularly hepatocellular carcinoma. For example, in May 2023, ABK Biomedical, a Canada-based medical device company, obtained Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate a multicenter pivotal study involving Eye90 microspheres for hepatocellular carcinoma. Eye90 microspheres represent a novel Y90 radioembolization technology, manufactured through a proprietary process that yields microspheres with a uniform size distribution and high radioactivity concentration. The design of these microspheres is intended to deliver a significant radiation dose to the tumor while minimizing exposure to healthy tissue.
Tumor Embolization Devices Market Leading Companies And Competitive Benchmarking
Major companies operating in the tumor embolization devices market are Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Kaneka Corporation, Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Surefire Medical Inc., Varian Medical Systems Inc.
View The Full Tumor Embolization Devices Market Report:
Tumor Embolization Devices Market Top Region By Revenue And Market Share
North America was the largest region in the tumor embolization devices market in 2025. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
